Credit Suisse’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $11.4M | Buy |
143,883
+1,940
| +1% | +$159K | 0.01% | 863 |
|
|
2023
Q4 | $11M | Buy |
141,943
+8,828
| +7% | +$653K | 0.01% | 884 |
|
|
2023
Q3 | $9.36M | Sell |
133,115
-356
| -0.3% | -$26.6K | 0.01% | 929 |
|
|
2023
Q2 | $10.6M | Buy |
133,471
+18,307
| +16% | +$1.32M | 0.01% | 898 |
|
|
2023
Q1 | $8.32M | Buy |
115,164
+5,431
| +5% | +$423K | 0.01% | 1021 |
|
|
2022
Q4 | $9.03M | Buy |
109,733
+25,589
| +30% | +$2.11M | 0.01% | 974 |
|
|
2022
Q3 | $6.58M | Buy |
84,144
+4,850
| +6% | +$388K | 0.01% | 1112 |
|
|
2022
Q2 | $5.36M | Buy |
79,294
+1,179
| +2% | +$82.2K | 0.01% | 1242 |
|
|
2022
Q1 | $5.12M | Buy |
78,115
+3,333
| +4% | +$194K | ﹤0.01% | 1427 |
|
|
2021
Q4 | $4.54M | Sell |
74,782
-13,158
| -15% | -$785K | ﹤0.01% | 2091 |
|
|
2021
Q3 | $5.61M | Buy |
87,940
+4,808
| +6% | +$304K | ﹤0.01% | 1960 |
|
|
2021
Q2 | $5.22M | Sell |
83,132
-7,069
| -8% | -$443K | ﹤0.01% | 2049 |
|
|
2021
Q1 | $5.15M | Buy |
90,201
+21,137
| +31% | +$1.14M | ﹤0.01% | 2047 |
|
|
2020
Q4 | $3.47M | Sell |
69,064
-11,177
| -14% | -$445K | ﹤0.01% | 2390 |
|
|
2020
Q3 | $2.37M | Buy |
80,241
+5,514
| +7% | +$160K | ﹤0.01% | 2302 |
|
|
2020
Q2 | $1.88M | Sell |
74,727
-237,039
| -76% | -$5.92M | ﹤0.01% | 2429 |
|
|
2020
Q1 | $5.72M | Sell |
311,766
-116,170
| -27% | -$3.33M | ﹤0.01% | 1477 |
|
|
2019
Q4 | $14.2M | Buy |
427,936
+372,506
| +672% | +$11.7M | 0.01% | 1218 |
|
|
2019
Q3 | $1.72M | Buy |
55,430
+550
| +1% | +$16.7K | ﹤0.01% | 2589 |
|
|
2019
Q2 | $1.92M | Sell |
54,880
-876,246
| -94% | -$28.3M | ﹤0.01% | 2486 |
|
|
2019
Q1 | $27.3M | Buy |
931,126
+878,191
| +1,659% | +$24.9M | 0.02% | 698 |
|
|
2018
Q4 | $1.36M | Sell |
52,935
-8,795
| -14% | -$304K | ﹤0.01% | 2543 |
|
|
2018
Q3 | $2.17M | Buy |
61,730
+2,712
| +5% | +$108K | ﹤0.01% | 2286 |
|
|
2018
Q2 | $2.42M | Sell |
59,018
-4,487
| -7% | -$181K | ﹤0.01% | 2298 |
|
|
2018
Q1 | $2.49M | Sell |
63,505
-608,223
| -91% | -$22.3M | ﹤0.01% | 2247 |
|
|
2017
Q4 | $21.9M | Buy |
671,728
+604,319
| +896% | +$20.9M | 0.02% | 835 |
|
|
2017
Q3 | $3.22M | Sell |
67,409
-65,020
| -49% | -$3.17M | ﹤0.01% | 2144 |
|
|
2017
Q2 | $6.54M | Buy |
132,429
+73,088
| +123% | +$3.24M | 0.01% | 1452 |
|
|
2017
Q1 | $2.59M | Sell |
59,341
-90,175
| -60% | -$3.66M | ﹤0.01% | 2158 |
|
|
2016
Q4 | $4.95M | Buy |
149,516
+66,676
| +80% | +$2.59M | ﹤0.01% | 1654 |
|
|
2016
Q3 | $4.11M | Buy |
82,840
+25,721
| +45% | +$1.34M | ﹤0.01% | 1815 |
|
|
2016
Q2 | $3.17M | Sell |
57,119
-10,445
| -15% | -$611K | ﹤0.01% | 1994 |
|
|
2016
Q1 | $3.72M | Sell |
67,564
-21,843
| -24% | -$1.25M | ﹤0.01% | 1743 |
|
|
2015
Q4 | $5.58M | Buy |
89,407
+11,343
| +15% | +$739K | 0.01% | 1500 |
|
|
2015
Q3 | $5.17M | Sell |
78,064
-56,557
| -42% | -$4.35M | 0.01% | 1541 |
|
|
2015
Q2 | $10.5M | Buy |
134,621
+95,344
| +243% | +$6.86M | 0.01% | 1215 |
|
|
2015
Q1 | $2.81M | Buy |
39,277
+3,160
| +9% | +$203K | ﹤0.01% | 2107 |
|
|
2014
Q4 | $2.21M | Buy |
36,117
+10,855
| +43% | +$632K | ﹤0.01% | 2462 |
|
|
2014
Q3 | $1.23M | Sell |
25,262
-40,976
| -62% | -$2M | ﹤0.01% | 2876 |
|
|
2014
Q2 | $3.02M | Buy |
66,238
+25,596
| +63% | +$1.12M | ﹤0.01% | 2368 |
|
|
2014
Q1 | $1.83M | Sell |
40,642
-10,001
| -20% | -$493K | ﹤0.01% | 2585 |
|
|
2013
Q4 | $2.4M | Buy |
50,643
+25,712
| +103% | +$1.12M | ﹤0.01% | 2507 |
|
|
2013
Q3 | $983K | Sell |
24,931
-4,066
| -14% | -$151K | ﹤0.01% | 2978 |
|
|
2013
Q2 | $959K | Buy |
+28,997
| New | +$941K | ﹤0.01% | 2828 |
|
Other funds holding ACHC
Credit Suisse's ACHC Position: Q1 2024 in Review
Credit Suisse increased its Acadia Healthcare (ACHC) stake by 1.4% in Q1 2024, buying an estimated $159K and bringing the position to 143,883 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #863.
Credit Suisse first reported a position in ACHC in Q2 2013 and has held it in 44 quarters since. The position peaked at $27.3M in Q1 2019. 322 funds tracked by Wall St. Rank hold ACHC as of Q1 2024.
- Credit Suisse held 143,883 shares of Acadia Healthcare worth $11.4M as of Q1 2024.
- Credit Suisse bought 1,940 Acadia Healthcare shares in Q1 2024, an estimated $159K.
- Acadia Healthcare made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #863 holding.
- Credit Suisse first reported a position in Acadia Healthcare in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Acadia Healthcare position peaked at $27.3M in Q1 2019.
- 322 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.